Table 2

Median (IQR) and log transformed percentage increases for endothelial function in the exercise and control groups

Microvascular dependent
Ach
Microvascular independent
SNP
Macrovascular dependent
FMD
Macrovascular independent
GTN
Exercise group
 baseline271.4 (133.3–485.7)190.5 (107.8–365.7)9.4 (2.2–10.8)18.7 (12.9–22.8)
 3-months394.1 (288.5–600.0)423.9 (227.6–608.1)18.2 (11.5–24.7)24.6 (21.0–30.1)
 6-months434.1 (244.7–644.7)545.8 (303.8–700.1)16.7 (12.6–26.7)26.1 (19.3–38.7)
 log baseline2.4±0.52.3±0.40.8±0.41.2±0.2
 log 3-months2.5±0.22.6±0.31.2±0.2*1.4±0.1**
 log 6-months2.7±0.4*2.7±0.2*1.2±0.2*1.4±0.2
Control group
 baseline331.8 (184.6–454.0)318.1 (181.2–531.8)7.4 (3.4–14.2)20.9 (15.0–28.8)
 3-months275.9 (155.3–471.6)241.7 (139.8–630.8)9.9 (3.7–15.5)15.0 (12.4–22.9)
 6-months235.7 (142.9–428.1)249.8 (142.9–547.0)7.9 (4.1–18.9)27.0 (11.4–30.9)
 log baseline2.4±0.22.4±0.40.8±0.41.3±0.2
 log 3-months2.3±0.42.5±0.30.9±0.41.2±0.2
 log 6-months2.3±0.42.5±0.40.9±0.31.3±0.3
  • Repeated measures analysis of variance in the log values: significant from baseline * p<0.05 and **p<0.001.

  • Ach, acetylcholine; FMD, flow-mediated dilatation; GTN, glyceryl trinitrate; SNP, sodium nitroprusside.